ÜbersichtsarbeitOpen access
Regulatory affairs and biotechnology in Europe: III. Introduction into good regulatory practice — Validation of virus removal and inactivation
Biotherapy · 1993
DOI: 10.1007/bf01877422 ↗At a glance
Übersichtsarbeit in Biotherapy, 1993. Written by B Trijzelaar. Institution: Strategic Biotech International, Zeist, The Netherlands. Cited 11 times so far (Crossref). The full text is freely available in PubMed Central.
Abstract (original language)
No hay resumen disponible.
Subjects
MeSH terms (MEDLINE)
AnimalsBiotechnologyEuropean UnionGuidelines as TopicHumansQuality ControlReproducibility of ResultsViruses
Authors and institutions
- Strategic Biotech International, Zeist, The Netherlands.
Cite
APA
Trijzelaar, B. (1993). Regulatory affairs and biotechnology in Europe: III. Introduction into good regulatory practice — Validation of virus removal and inactivation. Biotherapy. https://doi.org/10.1007/bf01877422
Vancouver
Trijzelaar B. Regulatory affairs and biotechnology in Europe: III. Introduction into good regulatory practice — Validation of virus removal and inactivation. Biotherapy. 1993. doi:10.1007/bf01877422
BibTeX
@article{Trijzelaar1993,
author = {Trijzelaar, B},
title = {Regulatory affairs and biotechnology in Europe: III. Introduction into good regulatory practice — Validation of virus removal and inactivation},
journal = {Biotherapy},
year = {1993},
doi = {10.1007/bf01877422}
}
EUVIMED